晚期胃癌-话题@MedSci

#晚期胃癌#

96篇内容 | 4259人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1276623, encodeId=f17812e66236c, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Nat Commun：Ⅱ期随机临床试验: 局部晚期胃癌患者新辅助FLOT与SOX疗法较量, objectType=article, longId=203999, objectId=4c6120399925, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c6120399925, replyNumber=0, likeNumber=63, createdTime=2020-12-03, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c6120399925, moduleTitle=Nat Commun：Ⅱ期随机临床试验: 局部晚期胃癌患者新辅助FLOT与SOX疗法较量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c6120399925)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276622, encodeId=e81612e66221b, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=J Clin Oncol：III期 | 一线诱导化疗后Avelumab维持治疗对晚期胃癌患者预后的作用, objectType=article, longId=203571, objectId=92742035e184, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92742035e184, replyNumber=0, likeNumber=85, createdTime=2020-11-22, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92742035e184, moduleTitle=J Clin Oncol：III期 | 一线诱导化疗后Avelumab维持治疗对晚期胃癌患者预后的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92742035e184)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276621, encodeId=036912e6621c6, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Derazantinib治疗晚期胃癌：即将开展I/II期研究, objectType=article, longId=201355, objectId=2779201355ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2779201355ed, replyNumber=0, likeNumber=81, createdTime=2020-09-30, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2779201355ed, moduleTitle=Derazantinib治疗晚期胃癌：即将开展I/II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2779201355ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276620, encodeId=6f9012e6620ed, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Gastric Cancer：波齐替尼联合紫杉醇和曲妥珠单抗治疗HER2阳性晚期胃癌患者的效果, objectType=article, longId=198092, objectId=8f48198092eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f48198092eb, replyNumber=0, likeNumber=66, createdTime=2020-07-28, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f48198092eb, moduleTitle=Gastric Cancer：波齐替尼联合紫杉醇和曲妥珠单抗治疗HER2阳性晚期胃癌患者的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f48198092eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276619, encodeId=faf012e6619d0, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Lancet Oncol：乐伐替尼联合派姆单抗治疗晚期胃癌, objectType=article, longId=196434, objectId=1726196434bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1726196434bb, replyNumber=0, likeNumber=52, createdTime=2020-06-26, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1726196434bb, moduleTitle=Lancet Oncol：乐伐替尼联合派姆单抗治疗晚期胃癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1726196434bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276618, encodeId=9de312e661826, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Lancet oncol：仑伐替尼和派姆单抗联合治疗晚期胃癌, objectType=article, longId=196409, objectId=534919640909, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=534919640909, replyNumber=0, likeNumber=78, createdTime=2020-06-26, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=534919640909, moduleTitle=Lancet oncol：仑伐替尼和派姆单抗联合治疗晚期胃癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=534919640909)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276617, encodeId=ea2d12e661749, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=NEJM: Trastuzumab Deruxtecan治疗HER2阳性晚期胃癌II期效果显著, objectType=article, longId=196097, objectId=c0f719609e16, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0f719609e16, replyNumber=0, likeNumber=77, createdTime=2020-06-20, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0f719609e16, moduleTitle=NEJM: Trastuzumab Deruxtecan治疗HER2阳性晚期胃癌II期效果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0f719609e16)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276616, encodeId=f20912e661642, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Gastric Cancer：L1甲基化与肿瘤浸润淋巴细胞的组合可作为晚期胃癌的预后指标 , objectType=article, longId=193856, objectId=ff2119385640, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff2119385640, replyNumber=0, likeNumber=103, createdTime=2020-05-11, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff2119385640, moduleTitle=Gastric Cancer：L1甲基化与肿瘤浸润淋巴细胞的组合可作为晚期胃癌的预后指标 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff2119385640)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276615, encodeId=cafd12e6615b9, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=免疫治疗时代下的晚期胃癌治疗, objectType=article, longId=192419, objectId=c40019241934, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c40019241934, replyNumber=0, likeNumber=96, createdTime=2020-04-19, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c40019241934, moduleTitle=免疫治疗时代下的晚期胃癌治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c40019241934)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276614, encodeId=f3f212e66143e, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=JAMA Surg：新辅助化疗后腹腔镜远端局部晚期胃癌的疗效, objectType=article, longId=185410, objectId=e22b185410d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e22b185410d3, replyNumber=0, likeNumber=54, createdTime=2019-12-31, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e22b185410d3, moduleTitle=JAMA Surg：新辅助化疗后腹腔镜远端局部晚期胃癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e22b185410d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276613, encodeId=5fc912e66131c, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Gastric Cancer： L1甲基化与肿瘤浸润淋巴细胞的组合可作为晚期胃癌的预后指标, objectType=article, longId=184837, objectId=6ba418483e52, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ba418483e52, replyNumber=0, likeNumber=60, createdTime=2019-12-18, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ba418483e52, moduleTitle=Gastric Cancer： L1甲基化与肿瘤浸润淋巴细胞的组合可作为晚期胃癌的预后指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ba418483e52)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276612, encodeId=3aa612e66120b, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Gastric Cancer：不可切除的晚期胃癌患者血清碱性磷酸酶和乳酸脱氢酶水平的预后意义, objectType=article, longId=181684, objectId=d3a6181684c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3a6181684c4, replyNumber=0, likeNumber=60, createdTime=2019-10-23, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3a6181684c4, moduleTitle=Gastric Cancer：不可切除的晚期胃癌患者血清碱性磷酸酶和乳酸脱氢酶水平的预后意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3a6181684c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276611, encodeId=029912e66110c, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=局部晚期胃癌优化治疗模式的探寻, objectType=article, longId=181034, objectId=0902181034b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0902181034b7, replyNumber=0, likeNumber=66, createdTime=2019-10-14, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0902181034b7, moduleTitle=局部晚期胃癌优化治疗模式的探寻, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0902181034b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276610, encodeId=764c12e6610fe, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=【2019 ESMO】林榕波教授团队报道四药联合方案治疗晚期胃癌, objectType=article, longId=180680, objectId=779218068058, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=779218068058, replyNumber=0, likeNumber=88, createdTime=2019-10-10, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=779218068058, moduleTitle=【2019 ESMO】林榕波教授团队报道四药联合方案治疗晚期胃癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=779218068058)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276609, encodeId=0bf812e660935, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=JAMA Surg：腹腔镜远端胃切除术联合新辅助化疗治疗局部晚期胃癌, objectType=article, longId=180291, objectId=a7cc180291c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7cc180291c5, replyNumber=0, likeNumber=62, createdTime=2019-10-01, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7cc180291c5, moduleTitle=JAMA Surg：腹腔镜远端胃切除术联合新辅助化疗治疗局部晚期胃癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7cc180291c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276608, encodeId=37a312e66083c, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Oncologie宣布与Merck进行临床试验合作，评估Bavituximab与PD-1单抗KEYTRUDA联合治疗晚期胃癌或胃食管癌, objectType=article, longId=177568, objectId=24091e7568e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24091e7568e4, replyNumber=0, likeNumber=65, createdTime=2019-08-15, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24091e7568e4, moduleTitle=Oncologie宣布与Merck进行临床试验合作，评估Bavituximab与PD-1单抗KEYTRUDA联合治疗晚期胃癌或胃食管癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24091e7568e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276607, encodeId=9d9712e66077c, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=JAMA Surg：手术联合术中腹腔灌洗与单独手术治疗局部晚期胃癌的效果比较, objectType=article, longId=177459, objectId=71d31e745933, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71d31e745933, replyNumber=0, likeNumber=61, createdTime=2019-08-13, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71d31e745933, moduleTitle=JAMA Surg：手术联合术中腹腔灌洗与单独手术治疗局部晚期胃癌的效果比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71d31e745933)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276606, encodeId=9a0712e66069f, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Gastric Cancer：不能手术切除的晚期胃癌患者血清碱性磷酸酶和乳酸脱氢酶水平的预后意义, objectType=article, longId=176922, objectId=6fb01e692241, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6fb01e692241, replyNumber=0, likeNumber=53, createdTime=2019-08-06, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6fb01e692241, moduleTitle=Gastric Cancer：不能手术切除的晚期胃癌患者血清碱性磷酸酶和乳酸脱氢酶水平的预后意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6fb01e692241)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276605, encodeId=36f412e660587, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Gastric Cancer：早期和晚期胃癌中印戒细胞腺癌的临床病理学差异, objectType=article, longId=176901, objectId=ec131e690172, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec131e690172, replyNumber=0, likeNumber=58, createdTime=2019-08-06, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec131e690172, moduleTitle=Gastric Cancer：早期和晚期胃癌中印戒细胞腺癌的临床病理学差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec131e690172)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276604, encodeId=0cee12e660414, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=2019年ESMO-GI：TAS-118联合奥沙利铂显著延长晚期胃癌患者的生存期, objectType=article, longId=175278, objectId=115d1e52785c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=115d1e52785c, replyNumber=0, likeNumber=74, createdTime=2019-07-13, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=115d1e52785c, moduleTitle=2019年ESMO-GI：TAS-118联合奥沙利铂显著延长晚期胃癌患者的生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=115d1e52785c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

晚期胃癌

2020-05-29

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Nat Commun：Ⅱ期随机临床试验: 局部晚期胃癌患者新辅助FLOT与SOX疗法较量

2020-12-03

爆笑小医 (审核中...)

前往app查看评论内容

#晚期胃癌#

J Clin Oncol：III期 | 一线诱导化疗后Avelumab维持治疗对晚期胃癌患者预后的作用

2020-11-22

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Derazantinib治疗晚期胃癌：即将开展I/II期研究

2020-09-30

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Gastric Cancer：波齐替尼联合紫杉醇和曲妥珠单抗治疗HER2阳性晚期胃癌患者的效果

2020-07-28

docwu2019 (审核中...)

前往app查看评论内容

#晚期胃癌#

Lancet Oncol：乐伐替尼联合派姆单抗治疗晚期胃癌

2020-06-26

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Lancet oncol：仑伐替尼和派姆单抗联合治疗晚期胃癌

2020-06-26

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

NEJM: Trastuzumab Deruxtecan治疗HER2阳性晚期胃癌II期效果显著

2020-06-20

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Gastric Cancer：L1甲基化与肿瘤浸润淋巴细胞的组合可作为晚期胃癌的预后指标

2020-05-11

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

免疫治疗时代下的晚期胃癌治疗

2020-04-19

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

JAMA Surg：新辅助化疗后腹腔镜远端局部晚期胃癌的疗效

2019-12-31

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Gastric Cancer： L1甲基化与肿瘤浸润淋巴细胞的组合可作为晚期胃癌的预后指标

2019-12-18

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Gastric Cancer：不可切除的晚期胃癌患者血清碱性磷酸酶和乳酸脱氢酶水平的预后意义

2019-10-23

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

局部晚期胃癌优化治疗模式的探寻

2019-10-14

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

【2019 ESMO】林榕波教授团队报道四药联合方案治疗晚期胃癌

2019-10-10

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

JAMA Surg：腹腔镜远端胃切除术联合新辅助化疗治疗局部晚期胃癌

2019-10-01

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Oncologie宣布与Merck进行临床试验合作，评估Bavituximab与PD-1单抗KEYTRUDA联合治疗晚期胃癌或胃食管癌

2019-08-15

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

JAMA Surg：手术联合术中腹腔灌洗与单独手术治疗局部晚期胃癌的效果比较

2019-08-13

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Gastric Cancer：不能手术切除的晚期胃癌患者血清碱性磷酸酶和乳酸脱氢酶水平的预后意义

2019-08-06

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Gastric Cancer：早期和晚期胃癌中印戒细胞腺癌的临床病理学差异

2019-08-06

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

2019年ESMO-GI：TAS-118联合奥沙利铂显著延长晚期胃癌患者的生存期

2019-07-13

科室
- - 订阅+
  - 更多科室
工具
服务